about
Cell death programs in Yersinia immunity and pathogenesisTemporal Progression of Pneumonic Plague in Blood of Nonhuman Primate: A Transcriptomic AnalysisPlague Vaccine Development: Current Research and Future TrendsMutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccinesYersinia pestis survival and replication within human neutrophil phagosomes and uptake of infected neutrophils by macrophages.Yersiniabactin reduces the respiratory oxidative stress response of innate immune cellsDirect neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrVDeletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.Multiple roles of Myd88 in the immune response to the plague F1-V vaccine and in protection against an aerosol challenge of Yersinia pestis CO92 in mice.A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in miceHistopathological observation of immunized rhesus macaques with plague vaccines after subcutaneous infection of Yersinia pestis.Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa.An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plagueYersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaquesLcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.Bioluminescence imaging to track bacterial dissemination of Yersinia pestis using different routes of infection in miceYersinia pestis intracellular parasitism of macrophages from hosts exhibiting high and low severity of plagueTNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model.A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.A comprehensive study on the role of the Yersinia pestis virulence markers in an animal model of pneumonic plague.Model systems to study plague pathogenesis and develop new therapeuticsYersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plagueIntranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plagueSelective Protective Potency of Yersinia pestis ΔnlpD MutantsType III secretion system-dependent translocation of ectopically expressed Yop effectors into macrophages by intracellular Yersinia pseudotuberculosis.Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine.Comparison of virulence between the Yersinia pestis Microtus 201, an avirulent strain to humans, and the vaccine strain EV in rhesus macaques, Macaca mulattaExpression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein ParticlesProtection against pneumonic plague following oral immunization with a non-replicating vaccine.Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.Early sensing of Yersinia pestis airway infection by bone marrow cells.Asparagine deprivation mediated by Salmonella asparaginase causes suppression of activation-induced T cell metabolic reprogramming.Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Antigen-specific Vgamma2Vdelta2 T effector cells confer homeostatic protection against pneumonic plaque lesions.Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library
P2860
Q21131303-0B8881FF-20D2-461B-A468-1474DFA58ED2Q27317068-D1175467-4A11-4666-AD40-B945B9C317ECQ28066875-71ED565E-6474-4569-8D33-80A484BF0347Q28678943-1027B84E-5D34-464E-85FE-2CDE9DFE07D0Q30571714-FA3A93AC-F407-4C8F-B33E-EDC85F50A3AAQ33521195-EC9FAF22-0F34-4501-A2B6-E2BB6E42B587Q33601814-36F31A03-7007-4F38-B5CE-1215A812B08CQ33603015-F70F05E3-FD8C-4F40-8B92-B06FF116F7F9Q33786763-2CC92562-B61F-4B54-B70A-16EE43548ED8Q33801151-F7EEBECE-038F-4B40-BA7B-1B5DA8EE68ACQ33877252-EAB20E60-FE2A-46D6-B8C0-C08DE62D74DDQ33895097-80A69E19-852F-4933-81C9-0B0469DAD807Q34045080-C6CFD559-0A05-45E6-AB0E-59566818B8AAQ34163944-ACCDEF36-3A01-43F3-A15E-A27EDC8304D3Q34290878-1A877D99-857D-485E-B24F-7664432E8F5BQ34298699-3098C76B-9038-410C-97CD-1F8D62DC68A4Q34349999-C61469B1-9172-4681-B02E-8635EF0077F0Q34359637-B9C10328-8447-42B8-B914-C1E27C74B8A2Q34380204-B94911DF-FCD4-4D05-8B5A-7F7AFC230A13Q34633478-57DBAD0F-E3BD-40FE-BDC9-91E30EBE6630Q34778198-DFC4540C-AB74-4939-A297-C5C39ECA32D9Q34819434-AEC6F0A9-CD76-4E57-9F35-3D5F53AB96F6Q35028538-0BD014CA-1D5F-472E-BA30-011C191554B2Q35029718-E890F2FF-E85E-491C-894D-77C2086FD37EQ35091255-3A21D990-4161-4152-B7E2-B33EBDDC52EBQ35530270-AABC113D-7A52-4B70-AA43-A9AE9DEC4402Q35540412-0EEF9CDE-6BB2-4878-BB80-D74CF9AFF641Q35671617-28E6E397-FFC3-444F-8272-D52FD3F847E4Q35826610-64F91F42-ED25-4B9F-A11B-D6EC8EC0C2C9Q35886483-F98F433D-99B9-4052-BD66-94EE798C0B75Q35970485-E0A1508E-7286-47B0-B23A-E52A2069AC7BQ36099515-D0A00E15-5021-4DB4-951B-E6455D4ED92BQ36316792-E0623FE5-8196-436B-86BA-357E68B7E786Q36421830-2184E7EB-5C38-4386-96CA-5B59FDF1AD9DQ36477909-A63EE184-BB1E-4831-A64D-7D11EEFA1CA9Q36606805-4C5A968D-56FD-4565-B286-C85A56463219Q36911486-F9212402-C3B2-48C0-A1D9-A836D00260F0Q37067254-A4AD2E70-52D1-48A8-B5DE-7C03A40FFD05Q37183021-176DFD94-60D4-4A14-AB1B-9E675E44D940Q37285685-1C433A4D-4226-4B8B-82A7-6CB3A1D80C3A
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Immune defense against pneumonic plague
@ast
Immune defense against pneumonic plague
@en
Immune defense against pneumonic plague.
@nl
type
label
Immune defense against pneumonic plague
@ast
Immune defense against pneumonic plague
@en
Immune defense against pneumonic plague.
@nl
prefLabel
Immune defense against pneumonic plague
@ast
Immune defense against pneumonic plague
@en
Immune defense against pneumonic plague.
@nl
P2860
P1476
Immune defense against pneumonic plague
@en
P2093
Stephen T Smiley
P2860
P304
P356
10.1111/J.1600-065X.2008.00674.X
P577
2008-10-01T00:00:00Z